Advanced

Prurigo nodularis - vid svårare symtom kan pregabalin övervägas.

Asplund, Monika LU ; Calling, Susanna LU ; Spirén, Anna and Svedman, Cecilia LU (2015) In Läkartidningen 112.
Abstract
Prurigo nodularis is a pruritic condition characterized by skin noduli. Different treatment options have been used with limited success. Pregabalin is a drug licensed for treatment of neuropathic pain in adults. As prurigo nodularis involves suffering for the patients and is difficult to treat, the aim of this case report is to report the effect of pregabalin treatment in seven patients with prurigo nodularis, treated in the dermatology clinic in Malmö, Sweden. Four patients experienced good effect of pregabalin, though two patients had a transient effect. Side effects of pregabalin have been reported. This case report indicates that pregabalin is a treatment option for therapy-resistant prurigo nodularis; even though one must be aware of... (More)
Prurigo nodularis is a pruritic condition characterized by skin noduli. Different treatment options have been used with limited success. Pregabalin is a drug licensed for treatment of neuropathic pain in adults. As prurigo nodularis involves suffering for the patients and is difficult to treat, the aim of this case report is to report the effect of pregabalin treatment in seven patients with prurigo nodularis, treated in the dermatology clinic in Malmö, Sweden. Four patients experienced good effect of pregabalin, though two patients had a transient effect. Side effects of pregabalin have been reported. This case report indicates that pregabalin is a treatment option for therapy-resistant prurigo nodularis; even though one must be aware of that the effect may not be permanent and that there are side effects. The aim must be to use the drug for a limited time, taking the patient to a remission state, where the vicious itch-scratch cycle can be inhibited. (Less)
Please use this url to cite or link to this publication:
author
organization
alternative title
Prurigo nodularis--pregabalin can be considered for more severe symptoms
publishing date
type
Contribution to journal
publication status
published
subject
in
Läkartidningen
volume
112
publisher
Sveriges Läkarförbund
external identifiers
  • PMID:26671429
  • Scopus:84949993816
ISSN
0023-7205
language
Swedish
LU publication?
yes
id
d7bb206f-4d8c-4b4f-bd98-6a2ccb62e1f4 (old id 8504686)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26671429?dopt=Abstract
date added to LUP
2016-01-05 13:01:57
date last changed
2016-10-13 04:30:56
@misc{d7bb206f-4d8c-4b4f-bd98-6a2ccb62e1f4,
  abstract     = {Prurigo nodularis is a pruritic condition characterized by skin noduli. Different treatment options have been used with limited success. Pregabalin is a drug licensed for treatment of neuropathic pain in adults. As prurigo nodularis involves suffering for the patients and is difficult to treat, the aim of this case report is to report the effect of pregabalin treatment in seven patients with prurigo nodularis, treated in the dermatology clinic in Malmö, Sweden. Four patients experienced good effect of pregabalin, though two patients had a transient effect. Side effects of pregabalin have been reported. This case report indicates that pregabalin is a treatment option for therapy-resistant prurigo nodularis; even though one must be aware of that the effect may not be permanent and that there are side effects. The aim must be to use the drug for a limited time, taking the patient to a remission state, where the vicious itch-scratch cycle can be inhibited.},
  author       = {Asplund, Monika and Calling, Susanna and Spirén, Anna and Svedman, Cecilia},
  issn         = {0023-7205},
  language     = {swe},
  publisher    = {ARRAY(0xa9112c8)},
  series       = {Läkartidningen},
  title        = {Prurigo nodularis - vid svårare symtom kan pregabalin övervägas.},
  volume       = {112},
  year         = {2015},
}